目次

Table of Contents

1. Executive Summary

2. Pulmonary Arterial Hypertension Market Characteristics

3. Pulmonary Arterial Hypertension Market Trends And Strategies

4. Impact Of COVID-19 On Pulmonary Arterial Hypertension

5. Pulmonary Arterial Hypertension Market Size And Growth
5.1. Global Pulmonary Arterial Hypertension Historic Market, 2016-2021, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Pulmonary Arterial Hypertension Forecast Market, 2021-2026F, 2031F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market

6. Pulmonary Arterial Hypertension Market Segmentation
6.1. Global Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Endothelin Receptor Antagonists (ERAs)
PDE-5 Inhibitors
Prostacyclin and Prostacyclin Analogs
SGC Stimulators
6.2. Global Pulmonary Arterial Hypertension Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Oral
Intravenous/ subcutaneous
Inhalational
6.3. Global Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Retail
Online

7. Pulmonary Arterial Hypertension Market Regional And Country Analysis
7.1. Global Pulmonary Arterial Hypertension Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
7.2. Global Pulmonary Arterial Hypertension Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

8. Asia-Pacific Pulmonary Arterial Hypertension Market
8.1. Asia-Pacific Pulmonary Arterial Hypertension Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
8.3. Asia-Pacific Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

9. China Pulmonary Arterial Hypertension Market
9.1. China Pulmonary Arterial Hypertension Market Overview
9.2. China Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
9.3. China Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

10. India Pulmonary Arterial Hypertension Market
10.1. India Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
10.2. India Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

11. Japan Pulmonary Arterial Hypertension Market
11.1. Japan Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
11.2. Japan Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

12. Australia Pulmonary Arterial Hypertension Market
12.1. Australia Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
12.2. Australia Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

13. Indonesia Pulmonary Arterial Hypertension Market
13.1. Indonesia Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
13.2. Indonesia Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

14. South Korea Pulmonary Arterial Hypertension Market
14.1. South Korea Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
14.2. South Korea Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

15. Western Europe Pulmonary Arterial Hypertension Market
15.1. Western Europe Pulmonary Arterial Hypertension Market Overview
15.2. Western Europe Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
15.3. Western Europe Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

16. UK Pulmonary Arterial Hypertension Market
16.1. UK Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
16.2. UK Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

17. Germany Pulmonary Arterial Hypertension Market
17.1. Germany Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
17.2. Germany Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

18. France Pulmonary Arterial Hypertension Market
18.4. France Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
18.5. France Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

19. Eastern Europe Pulmonary Arterial Hypertension Market
19.1. Eastern Europe Pulmonary Arterial Hypertension Market Overview
19.2. Eastern Europe Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
19.3. Eastern Europe Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

20. Russia Pulmonary Arterial Hypertension Market
20.1. Russia Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
20.2. Russia Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

21. North America Pulmonary Arterial Hypertension Market
21.1. North America Pulmonary Arterial Hypertension Market Overview
21.2. North America Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
21.3. North America Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

22. USA Pulmonary Arterial Hypertension Market
22.1. USA Pulmonary Arterial Hypertension Market Overview
22.2. USA Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
22.3. USA Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

23. South America Pulmonary Arterial Hypertension Market
23.1. South America Pulmonary Arterial Hypertension Market Overview
23.2. South America Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
23.3. South America Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

24. Brazil Pulmonary Arterial Hypertension Market
24.1. Brazil Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
24.2. Brazil Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

25. Middle East Pulmonary Arterial Hypertension Market
25.1. Middle East Pulmonary Arterial Hypertension Market Overview
25.2. Middle East Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
25.3. Middle East Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

26. Africa Pulmonary Arterial Hypertension Market
26.1. Africa Pulmonary Arterial Hypertension Market Overview
26.2. Africa Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
26.3. Africa Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

27. Pulmonary Arterial Hypertension Market Competitive Landscape And Company Profiles
27.1. Pulmonary Arterial Hypertension Market Competitive Landscape
27.2. Pulmonary Arterial Hypertension Market Company Profiles
27.2.1. United Therapeutics Corporation
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Bayer AG
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Gilead Sciences Inc.
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Johnson & Johnson
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. GlaxoSmithKline
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Pulmonary Arterial Hypertension Market

29. Pulmonary Arterial Hypertension Market Future Outlook and Potential Analysis

30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. The Business Research Company
30.5. Copyright And Disclaimer

List of Tables
Table 1: Global Historic Market Growth, 2016-2021, $ Billion
Table 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
Table 3: Global Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 4: Global Pulmonary Arterial Hypertension Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 5: Global Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 6: Global Pulmonary Arterial Hypertension Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 7: Global Pulmonary Arterial Hypertension Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 8: Asia-Pacific, Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 9: Asia-Pacific, Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 10: China, Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 11: China, Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 12: India, Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 13: India, Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 14: Japan, Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 15: Japan, Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 16: Australia, Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 17: Australia, Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 18: Indonesia, Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 19: Indonesia, Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 20: South Korea, Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 21: South Korea, Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 22: Western Europe, Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 23: Western Europe, Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 24: UK, Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 25: UK, Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 26: Germany, Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 27: Germany, Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 28: France, Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 29: France, Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 30: Eastern Europe, Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 31: Eastern Europe, Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 32: Russia, Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 33: Russia, Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 34: North America, Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 35: North America, Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 36: USA, Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 37: USA, Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 38: South America, Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 39: South America, Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 40: Brazil, Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 41: Brazil, Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 42: Middle East, Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 43: Middle East, Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 44: Africa, Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 45: Africa, Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 46: United Therapeutics Corporation Financial Performance
Table 47: Bayer AG Financial Performance
Table 48: Gilead Sciences Inc. Financial Performance
Table 49: Johnson & Johnson Financial Performance
Table 50: GlaxoSmithKline Financial Performance

List of Figures
Figure 1: Global Historic Market Growth, 2016-2021, $ Billion
Figure 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
Figure 3: Global Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 4: Global Pulmonary Arterial Hypertension Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 5: Global Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 6: Global Pulmonary Arterial Hypertension Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 7: Global Pulmonary Arterial Hypertension Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 8: Asia-Pacific, Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 9: Asia-Pacific, Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 10: China, Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 11: China, Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 12: India, Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 13: India, Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 14: Japan, Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 15: Japan, Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 16: Australia, Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 17: Australia, Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 18: Indonesia, Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 19: Indonesia, Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 20: South Korea, Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 21: South Korea, Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 22: Western Europe, Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 23: Western Europe, Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 24: UK, Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 25: UK, Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 26: Germany, Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 27: Germany, Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 28: France, Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 29: France, Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 30: Eastern Europe, Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 31: Eastern Europe, Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 32: Russia, Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 33: Russia, Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 34: North America, Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 35: North America, Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 36: USA, Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 37: USA, Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 38: South America, Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 39: South America, Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 40: Brazil, Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 41: Brazil, Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 42: Middle East, Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 43: Middle East, Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 44: Africa, Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 45: Africa, Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 46: United Therapeutics Corporation Financial Performance
Figure 47: Bayer AG Financial Performance
Figure 48: Gilead Sciences Inc. Financial Performance
Figure 49: Johnson & Johnson Financial Performance
Figure 50: GlaxoSmithKline Financial Performance